Table 2.
Study population N = 101 |
|
---|---|
Prevalence of eosinophilic phenotype | |
Blood Eosinophil count ≥ 300 cells/mm3 | 37 (36.6%) |
Absolute blood eosinophil count | |
Mean ± SD | 566.1 ± 221.7 |
Range | 300.0–1242.0 |
Median | 520.00 |
Blood eosinophil count ≥ 150 cells/mm3 | |
Absolute blood eosinophil count | 74 (73.3%) |
Mean ± SD | 393.3 ± 235.4 |
Range | 150.0 – 1242.0 |
Median | 299.8 |
Total serum IgE (IU/mL) | |
Mean ± SD | 488.0 ± 921.8 |
Range | 5.0 – 6220.0 |
Median | 173.00 |
Prevalence of atopic phenotype* | 68 (67.3%) |
Serum IgE levels, in IU/mL | |
Mean ± SD | 689.9 ± 1053.8 |
Range | 102.1 – 6220.0 |
Median | 302.5 |
Prevalence of overlapping atopy and eosinophilia | 26 (25.7%) |
Serum IgE levels, in IU/mL | 811.5 ± 1078.1 |
Blood eosinophil count, in cells/mm3 | 610.3 ± 235.2 |
IgE: immunoglobulin E; SD: standard deviation
*Total serum IgE > 100 IU/mL